Last $0.02 USD
Change Today 0.00 / 0.00%
Volume 0.0
IMMB On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 07/9/14 All times are local (Market data is delayed by at least 15 minutes).

immunotech laboratories inc (IMMB) Snapshot

Open
$0.02
Previous Close
$0.02
Day High
$0.02
Day Low
$0.02
52 Week High
03/28/14 - $0.10
52 Week Low
11/26/13 - $0.01
Market Cap
1.2M
Average Volume 10 Days
7.0K
EPS TTM
$36.27
Shares Outstanding
60.6M
EX-Date
--
P/E TM
0.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for IMMUNOTECH LABORATORIES INC (IMMB)

Related News

No related news articles were found.

immunotech laboratories inc (IMMB) Related Businessweek News

No Related Businessweek News Found

immunotech laboratories inc (IMMB) Details

Immunotech Laboratories, Inc., a development stage company, engages in the research and development of protein-based therapeutic and diagnostic products with applications in HIV/AIDS. The company holds licensing rights for the irreversible pepsin fraction (IPF) peptide molecule for the treatment and prevention of HIV/AIDS indication. It is developing novel therapeutic molecules for the treatment of HIV/AIDS, as well as for pediatric HIV/AIDS treatment, pre-natal HIV/AIDS treatment, and preventive HIV/AIDS vaccine. The company is based in Glendale, California.

4 Employees
Last Reported Date: 01/5/11

immunotech laboratories inc (IMMB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

immunotech laboratories inc (IMMB) Key Developments

Immunotech Laboratories, Inc. Files Form 15

Immunotech Laboratories, Inc. announced that it has filed Form 15 with the Securities and Exchange Commission to voluntarily deregister its common stock of par value $0.0001 per share under the Securities Exchange Act of 1934, as amended.

Immunotech Laboratories, Inc. Appoints Blaine Nabors as VP of Business Development

Immunotech Laboratories, Inc. has appointed Blaine Nabors as VP of Business Development. Commencing April 08, 2013, Blaine Nabors reached an agreement with the company for the position VP of Business Development. The position includes day-to-day operations along with assistance for the business marketing strategy and development along with brand marketing recognition. Additional duties will include assistance and communication for the FDA Strategy & Interaction, Regulatory Planning & Execution, Product Development and its Commercialization. Active involvement in development of a marketing strategy for prospective clients along with continued maintenance of public relations while reviewing, updating and guidance in creating a marketing plan that will generate relationships with Bio-medical companies within the same sector.

Immunotech Laboratories, Inc. Relocates to New Research & Development Laboratory Facility

Immunotech Laboratories, Inc. announced the company has relocated to a new Research & Development Lab facility in Monrovia, California. The new facility incorporates more laboratory use of the actual facility than the combined Administrative space at the previous Pasadena location. The new location also is geographically more conveniently located for the Immunotech team. In light of the recent announcements stating the HIV-AIDS and Hepatitis C clinical trials using the company's patented "ITV-1" patented technology treatment by the Immunotech BG sister company, more clinical research and results testing is necessary. The new facility accommodates the additional lab space. Utilizing a combination of the clinical tests and results being conducted in Bulgaria alongside the results analysis here in the USA at the new facility, Immunotech plans to submit all the results from the Bulgarian clinical trials for US Food & Drug Administration "FDA" approval on a pre IND meeting.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMMB:US $0.02 USD 0.00

IMMB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IMMB.
View Industry Companies
 

Industry Analysis

IMMB

Industry Average

Valuation IMMB Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNOTECH LABORATORIES INC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.